| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2021 | ASRT Assertio Holdings, Inc. | Patel Ajay | SVP And CAO | Buy | 8,170 | $1.53 | $12,500.00 | +81.5% | -36.3% | +111.4% | |
| May 20, 2021 | ZTS Zoetis Inc. | Knupp Catherine A. | Executive Vice President | Sell | 8,283 | $175.16 | $1,450,850.28 | -13.4% | +15.8% | -7.0% | |
| May 20, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Lee Howard | Director | Sell | 10,000 | $19.74 | $197,354.00 | -7.0% | -3.1% | +71.2% | |
| May 20, 2021 | ASRT Assertio Holdings, Inc. | Schwichtenberg Paul | SVP And CFO | Buy | 9,750 | $1.51 | $14,761.50 | +70.8% | -36.3% | +111.4% | |
| May 20, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 99,931 | $200.48 | $20,033,766.98 | - | +35.0% | +51.9% | |
| May 19, 2021 | ESPR Esperion Therapeutics, Inc. | Biotech Target N V55 | 10% Owner | Buy | 200,000 | $20.37 | $4,073,960.00 | +4.8% | -30.3% | -69.8% | |
| May 19, 2021 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 6,000 | $169.05 | $1,014,300.00 | -12.5% | +20.8% | -6.8% | |
| May 18, 2021 | ANIK Anika Therapeutics, Inc. | Henneman John B III | Director | Buy | 2,000 | $42.86 | $85,720.00 | +21.5% | -0.6% | -48.6% | |
| May 18, 2021 | LQDA Liquidia Corp | Schundler Russell58 | General Counsel | Buy | 97,755 | $2.77 | $270,817.83 | +121.5% | -4.7% | +104.7% | |
| May 18, 2021 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 150,000 | $21.90 | $3,285,405.00 | -15.9% | +28.4% | +31.9% | |
| May 17, 2021 | ALKS Alkermes Plc. | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sell | 50,000 | $22.09 | $1,104,650.00 | -18.7% | +27.2% | +34.5% | |
| May 17, 2021 | TCNNF Trulieve Cannabis Corp. | Thronson Susan | Director | Buy | 1,175 | $40.30 | $47,346.63 | +25.6% | - | - | |
| May 17, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | SVP Corp Admin Center | Sell | 12,823 | $19.98 | $256,139.68 | -10.7% | -3.2% | +80.0% | |
| May 17, 2021 | CPIX Cumberland Pharmaceuticals Inc | Cearnal Martin E47 | Sr Vp/ Chief Commercial Officer | Buy | 12,985 | $2.81 | $36,504.65 | +0.4% | +9.5% | -19.4% | |
| May 14, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 100 | $35.00 | $3,500.00 | - | -3.3% | -12.7% | |
| May 14, 2021 | ALKS Alkermes Plc. | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 2,250 | $22.23 | $50,017.50 | -2.9% | +30.1% | +20.8% | |
| May 14, 2021 | TXMD Therapeuticsmd, Inc. | Thompson Tommy G51 | Director | Buy | 5,000 | $1.06 | $5,300.00 | +0.7% | -15.2% | -94.2% | |
| May 14, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 18,119 | $19.71 | $357,170.36 | -8.9% | -2.2% | +77.0% | |
| May 13, 2021 | ALKS Alkermes Plc. | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sell | 25,000 | $22.39 | $559,695.00 | -10.3% | +28.6% | +20.9% | |
| May 13, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 25,827 | $19.34 | $499,434.78 | -38.5% | +1.8% | +80.7% | |
| May 13, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 11,876 | $35.44 | $420,891.99 | -0.4% | -2.6% | -11.7% | |
| May 12, 2021 | TLRY Tilray Brands, Inc. | Merton Carl A | Chief Financial Officer | Sell | 89,000 | $14.82 | $1,318,980.00 | -34.5% | +1.8% | -69.4% | |
| May 12, 2021 | ANIK Anika Therapeutics, Inc. | Land Raymond J | Director | Sell | 2,000 | $42.60 | $85,200.00 | -20.1% | -4.3% | -48.2% | |
| May 12, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 14,592 | $19.14 | $279,339.24 | -11.0% | +6.5% | +82.4% | |
| May 12, 2021 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 42,500 | $61.44 | $2,611,298.35 | -9.4% | -9.4% | -1.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.